Associate Fellow, Centre on Global Health Security
Kevin Outterson

Contact information


Kevin Outterson teaches health law and corporate law at Boston University, where he co-directs the health law programme.

He serves as the editor-in-chief of the Journal of Law, Medicine & Ethics; faculty co-advisor to the American Journal of Law & Medicine; past chair of the Section on Law, Medicine & Health Care of the Association of American Law Schools; and a member of the Board of the American Society of Law, Medicine & Ethics. 

He blogs on health policy issues at leading health policy blog, His research focuses on the organization and finance of the health sector.

Areas of specialization include global pharmaceutical markets, particularly antibiotics and other antimicrobials that can degrade in usefulness over time through resistance.

He led an interdisciplinary project on the legal ecology of antimicrobial resistance, funded in part by the Robert Wood Johnson Foundation program on public health law. 

He is a faculty affiliate at the Harvard Center for Communicable Disease Dynamics and an appointed member of the Antimicrobial Resistance Working Group at the CDC.

Areas of expertise

  • Health care markets
  • New business models for antibiotics
  • Global intellectual property, trade agreements & health
  • First Amendment issues in health care

Past experience

2007 - present Professor, Boston University School of Law; co-director of the Health Law Program
2010 - present 

Professor of Health Law, Bioethics, and Human Rights, Boston University School of Public Health 

2011 - present CDC, Antimicrobial Resistance Working Group 
2010 - present 

Faculty Affiliate, Center for Communicable Disease Dynamics, Harvard University